Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

chickenpox/groznica

Veza se sprema u međuspremnik
Stranica 1 iz 19 rezultatima

Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The (SARS CoV-2) virus is spreading globally, threatening all healthcare systems. Many healthcare systems and organizations are using different protocols and measures to fight the COVID-19. Hydroxychloroquine, lopinavir and other antiviral medications are currently under research investigations.

Immunisation Status and Safety of Vaccines in Italian MS Patients

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The different available treatments for MS influence the immune system in distinct ways and, therefore, may lead to specific infectious risks. Whereas immunomodulating therapies have no impact on infection risks [Cahill 2010; Winkelmann 2016], the most recent drugs with immunosuppressant activity

Systems Biology of Zoster Vaccine

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Varicella zoster virus (VZV) can cause two distinct diseases: chicken pox (varicella) and herpes zoster (shingles). The primary infection with VZV causes chicken pox, a widespread rash occurring with fever, mostly in childhood. The virus can then remain dormant in a person's body and has the ability

Evaluation of Different Methods for Diagnosis of ME

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
meningitis is a notifiable disease in many countries, the exact incidence rate is unknown. In 2013 meningitis resulted in 303,000 deaths - down from 464,000 deaths in 1990. In 2010 it was estimated that meningitis resulted in 420,000 deaths, excluding cryptococcal meningitis. Bacterial meningitis

Intestinal Response Patterns to Microbial Signals

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Only adults>18YO will be included, Two cohorts will be included: A cohort of CD patients (including specific sub-cohorts of recruited known & new-onset CD and travelling CD patients and archived pathological specimens of post-operative CD, total n=300) and a cohort of controls (healthy individuals

Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The purpose of this study is to determine the immune response from the new Shingrix vaccine in UC patients on tofacitinib monotherapy in comparison to other UC therapies. the investigators plan to determine this by vaccinating IBD patients on (a) tofacitinib monotherapy, (b) anti-TNF monotherapy,

Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Initiation of antiretroviral therapy (ART) can lead to a short-term increase of herpes virus-related illnesses including genital herpes flares, higher likelihood of varicella zoster virus (VZV), cytomegalovirus (CMV) uveitis or other end-organ disease, and herpes simplex virus (HSV) associated

Fever Observational Study

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Fever (high temperature) is a normal bodily response to an infection, which has shown to have a beneficial effect in humans with chickenpox, malaria and rhinovirus infections. In children it has been recommended by the National Institute for Health and Care Excellence not to cool down the child

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Study aim, background, and design Herpes Zoster (Shingles) is a major cause of pain and expense to the elderly and chronically ill. The incidence is estimated at 3 in 1,000 patients. Zostavax™ is a high dose, live varicella vaccine that has been validated in very large placebo control trials to

Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The emerging field of systems vaccinology offers an unbiased, global approach to studying immune responses to vaccines, unlike the traditional reductionist approaches that focus on specific arms of the immune system (1,2). Recent work has studied responses to the trivalent inactivated influenza

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Perennial allergic rhinitis may be defined clinically as an inflammatory condition of the nose characterised by nasal obstruction, sneezing, itching, or rhinorrhoea. It occurs due to an exaggerated response to an environmental trigger which results in inflammation of the lining of the nose; it is

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
VZV causes two clinical diseases, primary infection results in varicella (chickenpox) after which virus latent in dorsal root ganglion. Reactivation of VZV results in herpes zoster (shingles) about years or decades. Immunocompetent children, varicella generally mild self limiting illness. In HIV

A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
- This is a Phase I/II, randomized, observer-blind, controlled trial. Thirty-four flavivirus naïve infants will be randomized to the vaccine group and 17 infants to the control group. - Infants receive dengue vaccine at study months 0 and 6 or control vaccine (Varicella vaccine at study month 0 and
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge